MyAverix Finance
NS · Healthcare
Fabino Enterprises Ltd (543444)
Pharmaceuticals & Biotechnology
Fabino Enterprises Ltd (543444) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $42.70M, P/E ratio is -11.88, net margin is -0.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 543444
Fabino Enterprises Ltd (543444) — FAQ
What is Fabino Enterprises Ltd's market cap?
Fabino Enterprises Ltd (543444) has a reported market cap of $42.70M (data as of 2026-07-10).
What is 543444's P/E ratio?
The price-to-earnings (P/E) ratio for Fabino Enterprises Ltd (543444) is -11.88 (data as of 2026-07-10).
Does Fabino Enterprises Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Fabino Enterprises Ltd (543444). Check the MyAverix Finance app for the latest dividend data.
What sector is Fabino Enterprises Ltd in?
Fabino Enterprises Ltd (543444) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 543444 listed on?
543444 is listed on NS.
What is Fabino Enterprises Ltd's net margin?
Fabino Enterprises Ltd (543444) reports a net margin of -0.4% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.